3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Polycystic Ovary Syndrome
1
Overweight
1
Obesity
1
Insulin Resistance
1
Hyperandrogenism
1
Interventions
Metformin
91
Clomiphene
31
Letrozole
23
Inositol
19
Folic Acid
11
Chorionic Gonadotropin
11
Exercise
10
High-Intensity Interval Training
9
drospirenone and ethinyl estradiol combination
8
Ethinyl Estradiol
8
Contraceptives, Oral
8
Cholecalciferol
8
cetrorelix
7
Tablets
7
Progesterone
7
Menotropins
6
follitropin alfa
5
Pioglitazone
5
Liraglutide
5
Exenatide
5
Cyproterone Acetate
5
Caloric Restriction
5
Vitamin D
4
Triptorelin Pamoate
4
Surveys and Questionnaires
4
Sugars
4
Spironolactone
4
Glycoprotein Hormones, alpha Subunit
4
Fish Oils
4
Estradiol
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Polycystic Ovary Syndrome
×
licogliflozin
×
Clear all
NCT03152591
2021-01-05
PCOS
Novartis
Phase 2
Completed
29 enrolled
24 charts